Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain
Information source: Assiut University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Acute Pain; Chronic Pain
Intervention: local instillation of morphine to surgical wound (Drug)
Phase: Phase 2
Status: Recruiting
Sponsored by: Assiut University Official(s) and/or principal investigator(s): Shereen M Mohamed, MD, Principal Investigator, Affiliation: Lecturer of anesthesia, ICU and pain management- South Egypt Cancer Institute- Assuit University
Overall contact: Shereen M Mohamed, MD, Phone: 01006279209, Email: sheridouh79@yahoo.com
Summary
This study investigate the effect of addition morphine to locally instillation bupivacaine
on developing chronic neuropathic pain acute postoperative pain after breast cancer surgery
and on the probability of developing chronic neuropathic pain.
Clinical Details
Official title: Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: changes in acute pain intensity from the baseline
Secondary outcome: Postoperative adverse effectsThe probability of developing chronic neuropathic pain
Detailed description:
Breast cancer is one of the most common cancer diagnoses in women and a significant cause of
mortality and morbidity worldwide. Surgical treatment indicated in most patients. Persistent
pain and sensory disturbances following surgery is a significant clinical problem with an
average prevalence of 20-23. 9%. Post-mastectomy chronic pain syndrome (PMPS) is defined as
pain of neuropathic character located in the area of surgery and/or the ipsilateral arm,
present at least 4 days per week, and with an average intensity of at least 3 on a numeric
rating scale from 0 to 10. The pathological mechanisms may be related to patient
characteristics, surgical technique and adjuvant therapy. Although the genesis of pain is
multi-factorial, sectioning of the intercostobrachial nerve (a cutaneous branch of T1-2) is
the nerve lesion diagnosed most often.
Uncontrolled acute postoperative pain is defined as an important risk factor for the
development of chronic pain. Local anesthetics have been investigated in cancer breast
patients through many routes; paravertebral blocks, thoracic epidurals, wound infiltration,
topical lidocaine patch, and the topical application of EMLA( Eutectic Mixture of Local
Anesthetics) cream on operation site. Most of above studies suggested a better outcome in
terms of reduced postoperative pain and improved patient satisfaction.
Opioids exert a local analgesic effect is based on several observations: • Nociceptive
afferent nerve fibers contain peripheral opioid receptors which are silent except in the
presence of local inflammation. • Morphine and its metabolites are largely undetectable
systemically when applied topically to skin ulcers, suggesting the analgesic effect is local
• Peripheral opioid injections for local analgesia, such as intra-articular morphine after
knee surgery, have been found to be effective in several trials. An effective topical opioid
analgesic that could be applied to inflamed or open skin lesions would be a useful option
for some patients where other options for pain relief have been exhausted.
Eligibility
Minimum age: 30 Years.
Maximum age: 60 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- female patients with cancer breast scheduled for modified radical mastectomy with
axillary dissection
Exclusion Criteria:
- allergy to the study drugs
- significant cardiac, respiratory, renal or hepatic disease
- drug or alcohol abuse
- psychiatric illness that would interfere with perception and assessment of pain
Locations and Contacts
Shereen M Mohamed, MD, Phone: 01006279209, Email: sheridouh79@yahoo.com
Assiut University, Assiut 171516, Egypt; Recruiting
Additional Information
Starting date: January 2015
Last updated: August 3, 2015
|